Carcinogenic and therapeutic role of High-Mobility Group Box 1 in Cancer: is it a cancer facilitator, a cancer inhibitor or both?

WCRJ 2017; 4 (3) : e919
DOI: 10.32113/wcrj_20179_919

Soft tissue sarcomas of the limbs: multidisciplinary treatment

WCRJ 2017; 4 (3) : e917
DOI: 10.32113/wcrj_20179_917

Identification of known ABL Mutations by High Resolution Melt (HRM) Method as prevention of Imatinib-resistance

WCRJ 2017; 4 (3) : e915
DOI: 10.32113/wcrj_20179_915

Cancer Incidence pattern in Iran Provinces and Association with Human Development Index

WCRJ 2017; 4 (3) : e913
DOI: 10.32113/wcrj_20179_913

Lung cancer in the world: the incidence, mortality rate and risk factors

WCRJ 2017; 4 (3) : e911
DOI: 10.32113/wcrj_20179_911

Causes of Death of Cancer Patients in a Referral Hospital In Northern Iran between 2013 and 2016

WCRJ 2017; 4 (3) : e909
DOI: 10.32113/wcrj_20179_909

Breast cancer outcome in Africa is associated with socioeconomic development and health care setups

WCRJ 2017; 4 (2) : e890
DOI: 10.32113/wcrj_20176_890

Clinical and paraclinical manifestations in cancer patients referred to the emergency room of one tertiary hospital in Northern IRAN

WCRJ 2017; 4 (2) : e888
DOI: 10.32113/wcrj_20176_888

Identification of the level of perceived social support and hope of cancer patients and their families

WCRJ 2017; 4 (2) : e886
DOI: 10.32113/wcrj_20176_886

Impact of procedural pain in radiotherapy treatment

WCRJ 2017; 4 (2) : e884
DOI: 10.32113/wcrj_20176_884

• Newer
• 1
• …
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• …
• 48
• Older